港股异动 | 泰凌医药(01011)复牌一度跌超16% 接获港府要求协助查实第三方合约

Core Viewpoint - 泰凌医药's stock experienced significant volatility upon resuming trading, initially dropping over 16% before stabilizing to a decline of 8.97% at HKD 0.71, with a trading volume of HKD 2.8566 million [1] Group 1 - 泰凌医药 was temporarily suspended from trading prior to its resumption this morning [1] - The company received a request from Hong Kong government authorities to assist in verifying a contract related to an independent third party [1] - The matter raised by the authorities does not impact the company's daily operations [1] Group 2 - As of the announcement date, the company's directors and senior management have no legal liabilities related to the matter [1]